---
title: "QingSong Health Sets 2026 AGM to Renew Board and Seek 10% Share Buyback Mandate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284810464.md"
description: "QingSong Health Corporation has scheduled its annual general meeting for May 22, 2026, in Beijing. Shareholders will review the 2025 financial statements and consider the re-election of directors, setting of pay, and the reappointment of Deloitte as auditor. A key agenda item is a proposed mandate for a 10% share buyback to enhance capital management and shareholder returns. This move aims to maintain governance stability and optimize the capital structure within regulatory limits. QingSong Health operates in the health sector and is listed on the Hong Kong Stock Exchange."
datetime: "2026-04-30T16:14:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284810464.md)
  - [en](https://longbridge.com/en/news/284810464.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284810464.md)
---

# QingSong Health Sets 2026 AGM to Renew Board and Seek 10% Share Buyback Mandate

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

QingSong Health Corporation ( (HK:2661) ) has shared an update.

QingSong Health Corporation has convened its next annual general meeting for 22 May 2026 in Beijing, where shareholders will review the audited financial statements for the year ended 31 December 2025 and receive reports from the board and the external auditor. The meeting will also address board composition through the proposed re-election of one executive, one non-executive and three independent non-executive directors, alongside resolutions to set directors’ pay, reappoint Deloitte Touche Tohmatsu as auditor and grant the board a mandate to repurchase up to 10% of the company’s issued shares, potentially enhancing capital management flexibility and signaling a focus on shareholder returns.

If approved, the director re-elections would maintain continuity in QingSong Health’s governance structure, supporting stability as the company executes its health-focused strategy in China. The share repurchase mandate, bounded by Hong Kong listing rules and a defined validity period, would give the board additional tools to optimize the capital structure, manage earnings per share and respond to market conditions within clear regulatory limits.

**More about QingSong Health Corporation**

QingSong Health Corporation is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. Operating in the health sector, it focuses on providing health-related products and services to the mainland China market, with corporate governance and reporting aligned to Hong Kong listing standards.

**Average Trading Volume:** 645,167

**Current Market Cap:** HK$10.6B

For an in-depth examination of 2661 stock, go to TipRanks’ Overview page.

### Related Stocks

- [02661.HK](https://longbridge.com/en/quote/02661.HK.md)

## Related News & Research

- [QingSong Health Names Veteran Dealmaker as New CFO to Drive AI Health Growth](https://longbridge.com/en/news/286788421.md)
- [QingSong Health Sets March Board Meeting to Approve 2025 Results and Mull Dividend](https://longbridge.com/en/news/278543076.md)
- [China XLX Announces 2026 Q1 Results | CXLFF Stock News](https://longbridge.com/en/news/286673637.md)
- [Transactions in connection with share buyback programme](https://longbridge.com/en/news/286732631.md)
- [Nordic wins 2026 Swaay.Health award for health IT blog of the year](https://longbridge.com/en/news/286260284.md)